With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.
Candace Walker shares how connecting with others who have diabetes helped her feel less alone and better manage her condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback